Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.
Press releases published on August 19, 2025

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics
LOUISVILLE, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leader in personalized diagnostics, announced that the company is designated as a Thermo Fisher Scientific Center of Excellence (COE) as part of Thermo Fisher’s …

Rendever Rolls Out Immersive Dementia Simulation and Empathy Training for Improved Caregiving & Societal Understanding
BOSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rendever, the company leading the industry in immersive technology for aging, has launched a cutting-edge dementia and empathy training program for senior living professionals and caregivers. The interactive …

Trethera Awarded $3 Million NIH Grant to Advance First-In-Class Drug, TRE-515, for the Treatment of Lupus
LOS ANGELES, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that it has been awarded a $3 million Small …

Aeroflow Health Ranks No. 2,398 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, has announced that Aeroflow Health is No. 2,398 on the annual Inc. 5000 list, the most prestigious ranking …

Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a leading diversified holdings company dedicated to pioneering health and wellness solutions, today announced a groundbreaking strategic partnership …

Kyowa Kirin Premiers New CTCL Staging Tool for Healthcare Providers
PRINCETON, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc. a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced the launch of a new tool to help healthcare providers (HCPs) navigate the complicated process of accurately staging …

Global Cannabis Market Outlook 2025–2030: Rising Demand for Edibles, THC, and CBD Products
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to a research report published by MarketsandMarkets "Cannabis Market by Compound Type (THC-dominant, CBD-dominant, Balanced THC …

Students Are Struggling—Crisis Text Line Delivers Critical Mental Health Resources This Back-to-School Season
New York, Aug. 19, 2025 (GLOBE NEWSWIRE) -- As students across the country head back to school, the stress and anxiety of a new academic year can take a toll on their mental well-being. In 2024, nearly one in four Crisis Text Line conversations referenced …

Spark Biomedical Awarded Funding from Wellcome Leap for Women’s Health Innovation
Dallas, TX, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, the parent company of OhmBody, a women’s wellness division focused on wearable neurostimulation technology, has been selected as one of 13 organizations worldwide to receive funding from …

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
90-day trial measuring change in general fatigue in chronic babesiosis patients Enrollment expected to commence Q4 2025 and to be completed by Q2 2026 Site has clinical expertise in infectious disease trials and access to a robust patient population with …

Tria Federal Promotes Murali Mallina to Chief Technology Officer
ARLINGTON, Va., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tria Federal (Tria) has promoted Murali Mallina to be the company’s new Chief Technology Officer (CTO). As CTO, Mallina will lead Tria Labs, Tria’s technology innovation group, in developing and testing …

Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights
Submitted New Drug Application (NDA) to the FDA for lead asset CTx-1301 Anticipate FDA Decision in Q4 2025 regarding NDA Acceptance with Potential PDUFA Date in Mid-2026 KANSAS CITY, Kan., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a …

Cannabix Technologies delivers Marijuana Breath Test Hardware to Omega Laboratories Inc.
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has delivered multiple Cannabix Marijuana Breath Test (“MBT”) units to Omega …

Postbiotics Market Set to Surge: New Frontiers in Functional Foods and Skincare
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to research report published by MarketsandMarkets, The global postbiotics market is on an impressive upward trajectory, projected to increase from USD 146.7 million in 2025 to USD 224.8 million …

Walking Alone at Night is the Greatest Safety Fear of Women Nationwide -- Almost Half Say Safety Concerns Limit Daily Activities LogicMark Poll Reveals
LOUISVILLE, Ky., Aug. 19, 2025 (GLOBE NEWSWIRE) -- A comprehensive new national survey commissioned by LogicMark, Inc. (OTC: LGMK), a provider of personal safety devices, related to women’s safety exposes a stark reality: walking alone at night dominates …

Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-ever monthly …

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
LITTLETON, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …

Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
MELBOURNE, Australia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns were raised in the clinical hold notification regarding the BX004 drug candidate Enrollment and …

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black …